Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysis

about

Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysis

Item

http://www.wikidata.org/entity/Q41709594

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Efficacy and safety of traditi ...... plasm: a network meta-analysis

@en

type

Item

label

Efficacy and safety of traditi ...... plasm: a network meta-analysis

@en

prefLabel

Efficacy and safety of traditi ...... plasm: a network meta-analysis

@en

P1476

Efficacy and safety of traditi ...... plasm: a network meta-analysis

@en

P2093

Chenhao Li

http://www.w3.org/2001/XMLSchema#string

Gongliang Guo

http://www.w3.org/2001/XMLSchema#string

Haipeng Zhang

http://www.w3.org/2001/XMLSchema#string

Lili Yang

http://www.w3.org/2001/XMLSchema#string

Liqun Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials

Global cancer statistics, 2012

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.

Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study.

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.

The role of pegylated liposomal doxorubicin in ovarian cancer: a meta-analysis of randomized clinical trials

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

P304

59867-59877

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16729

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28938689

http://www.w3.org/2001/XMLSchema#string

P932

5601785

http://www.w3.org/2001/XMLSchema#string